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Abstract
In peroxisomes, peroxins (PEXs) 3 and 19 are the principal protein components of the machinery required for early
peroxisomal biogenesis. For further insight into the interaction of PEX3 and PEX19, we used hydrogen exchange mass
spectrometry to monitor conformational changes during complex formation between PEX3 and PEX19 in vitro. Our data
showed that PEX19 remained highly flexible during interaction with PEX3. However, we could detect three changes, one
each in the N-and C-terminus along with a small stretch in the middle of PEX19 (F64–L74) which became shielded from
hydrogen exchange when interacting with PEX3. PEX3 became more protected from hydrogen exchange in the binding
groove for PEX19 with only small changes elsewhere. Most likely the N-terminus of PEX19 initiates the binding to PEX3, and
then subtle conformational changes in PEX3 affect the surface of the PEX3 molecule. PEX19 in turn, is stabilized by folding
of a short helix and its C-terminal folding core permitting PEX19 to bind to PEX3 with higher affinity than just the N-terminal
interaction allows. Thus within the cell, PEX3 is stabilized by PEX19 preventing PEX3 aggregation.
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Introduction
Eukaryotic cells have membrane-bound organelles in order to
compartmentalize and organize cellular functions. One such
organelle is the peroxisome. Its biogenesis is orchestrated by
peroxins. In this study, we focus on one particular peroxin
complex of PEX3 and PEX19 [1–3].
Peroxisomes are single-membrane organelles varying in size,
shape, and biochemical content depending on cell type and
environmental requirements [4–6]. The importance of peroxi-
somes for normal mammalian development has been shown by
their linkage to many inherited diseases. These diseases can be
divided in to two groups. The first group is peroxisomal biogenesis
disorders (PBD) e.g. Zellweger syndrome and the second group is
peroxisomal disorders (PD). PBDs show that peroxisomes have
essential functions in lipid metabolism and free radical detoxifi-
cation. These disorders are linked to mutations in peroxins, a
diverse set of conserved proteins essential for peroxisome
biogenesis and maintenance. The PDs are caused by single
peroxisomal enzyme deficiencies [7–15]. Generally, dysfunctional
PEXs hamper peroxisomal matrix protein localization without
affecting the assembly of the peroxisomal membrane compart-
ment. In humans, a subset of peroxins consisting of PEX3, PEX19
and PEX16 are required for the initial steps of peroxisome
biogenesis [16–20].
PEX19 is an acidic, extended-shaped, soluble 33-kDa protein
with a farnesylated C-terminus. Limited proteolysis and circular
dichroism spectra analysis have shown that PEX19 is very flexible,
especially at the N-terminus [21]. It is mainly found in the cytosol,
but a small fraction resides in peroxisomal membranes [3,22–24].
The localization and cotranslational binding properties of PEX19
suggest that it is a cycling receptor. It is thought to function by first
binding peroxisomal membrane proteins (PMPs) in the cytosol to
prevent aggregation and then to carry the PMPs to the
peroxisomal membrane where the cargo-laden PEX19 interacts
with PEX3 resulting in PMP insertion into the membrane [25–
28]. PEX19 is finally released and recycled back to the cytosol
[3,29,30]. Interestingly, PEX19 has a large number of interaction
partner PMPs, but a C-terminally truncated form of PEX19 that
binds PEX3, cannot bind PMP22 and PMP70 [31]. This implies
that the binding of PEX3 is unique compared to other PMPs [26–
28,32–34]. Later findings have shed light on peroxisome
biogenesis. In vitro experiments have shown that PEX3 and
PEX19 are needed for preperoxisomal vesicle budding from the
ER [35]. These preperoxisomal vesicles fuse together through the
activity of PEX1 and PEX6 in Saccharomyces cerevisiae. After
fusion, the assembly of the full peroxisomal translocon occurs, and
the uptake of peroxisomal enzymes from the cytosol can begin
[36,37].
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PEX3 is a 42-kDa, peroxisomal, integral membrane protein.
The first 40 N-terminal residues in PEX3 contain both the
peroxisomal targeting signal and the single transmembrane
domain [18,38]. The rest of the protein is cytosolic, mediating
direct interaction with PEX19. The interaction has been partially
characterized through functional domain mapping, pentapeptide
insertion screening and by co-crystallization of PEX3 with N-
terminal peptides of PEX19 [19,39–41] revealing the atomic detail
of this interaction (Figure 1). However, detailed atomic resolution
information on the interaction of PEX3 in complex with the full
length PEX19 is still missing.
Intrinsically disordered proteins (IDP) are often found to
undergo limited folding upon binding and to use flexible regions
in partner recognition. Due to their structural flexibility they are
Figure 1. The full length human PEX3 protein sequence. A) The red letters indicate amino acids which are not expressed in the recombinant
protein. The black letters indicate amino acids modelled in the X-ray structure (PDB ID: 3AJB) [40]. The blue letters indicate amino acids which are not
modelled in the X-ray structure. B) X-ray structure of PEX3 with a PEX19 peptide bound (PDB ID: 3AJB). The secondary structure of PEX3 is colored as
a) helix (orange), b) sheet (dark blue) and c) coil (pink). The PEX19 peptide is shown in turquoise.
doi:10.1371/journal.pone.0103101.g001
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often able to carry out several functions [42,43]. In order to
further explore the interaction of just such a protein, PEX19, with
one of its interaction partners, PEX3, we utilized a method that
would allow us to identify changes in conformation occurring
because of the interaction. Hydrogen exchange mass spectrometry
(HXMS) reveals the solvent accessibility and stability of local areas
in protein samples in solution [44,45]. In this study we have used
HXMS to analyze the interaction between PEX3 and PEX19.
Our results establish that PEX19 is extremely dynamic. We found
that the N-terminal part of PEX19 binds to PEX3 as previously
shown [40,41]. In addition, we found two protected sites in PEX19
on interaction with PEX3.
Materials and Methods
Protein expression and cloning
A cloned human PEX3 in the pET32a vector was a kind gift of
Drs. Thilo Stehle and Gabriele Dodt, and has been previously
described [41]. The resulting recombinant fusion protein has an
N-terminal thioredoxin and His-tag followed by a TEV cleavage
site. This soluble PEX3 lacks a functional transmembrane region
as the reading frame starts from G25, and has a C235S mutation
to improve solubility. For expression of PEX3, E.coli Rosetta 2
(DE3) (Novagen) was transformed and grown overnight at 37uC in
Luria Bertani (LB) medium supplemented with 100 mg/ml
ampicillin (Sigma-Aldrich) and 34 mg/ml chloramphenicol (Sig-
ma-Aldrich). It was then diluted 100-fold in the same medium and
incubated under similar conditions until the OD600 reached 0.5.
The cultures were chilled at 4uC before isopropyl-b-thiogalacto-
pyranoside (IPTG; Fermentas) was added to a final concentration
of 0.5 mM. Incubation was continued at 18uC for 16–18 hours
before harvesting the cells by low speed centrifugation.
The human PEX19 ORF (Genbank CAG46859.1) was
amplified by PCR using an ImageGenes clone as template and
the primers: 59-GAAGAAGAACATATGGCCGCCGCTGAG-
GAAGG-39 and 59-GACGCCCTCGAGTCACATGATCAGA-
CACTGTTC-39. The PCR product was cloned using Nde I and
BamH I sites into the vector pCold I (Takara Bio Inc.) and verified
by DNA sequencing. Expression of the full length PEX19 with an
N-terminal His-tag was obtained by transforming the plasmid into
E.coli BL21(DE3) and growing the cells overnight at 37uC in LB
medium supplemented with 100 mg/ml ampicillin, diluted 100
fold in the same medium, and incubated under similar conditions
until the OD600 reached 0.5. The culture was then chilled at 4uC
for an hour before IPTG was added to a final concentration of
0.1 mM. Incubation was continued at 15uC for 16–18 h before
harvesting the cells by low speed centrifugation.
Protein purification
PEX3 was purified by resuspending pelleted cells in buffer A
(20 mM sodium phosphate, 300 mM NaCl, 5 mM b-mercapto-
ethanol, 25 mM imidazole, pH 8.0) and lysing with a french press
(Thermo Fisher Scientific). After centrifugation at 22 0006g for
30 min at 4uC, the supernatant was collected and incubated with
2 ml Ni-charged beads (IMAC, GE Healthcare) at 4uC, in a head
to head rotator for 30 min. The beads were collected by
centrifugation and then washed twice with 50 ml buffer A.
Tagged protein was eluted with buffer B (20 mM sodium
phosphate, 300 mM NaCl, 5 mM b-mercaptoethanol, 500 mM
imidazole, pH 8.0) and immediately diluted four-fold with buffer
C (20 mM sodium phosphate, 300 mM NaCl, 5 mM b-mercap-
toethanol, pH 8.0). The buffer was finally exchanged by ultrafil-
tration (10K cutoff, Amicon Ultra Millipore) into buffer C. To
remove the tag, PEX3 was digested with ProTEV protease
(Promega, #V6051). ProTEV buffer (Promega) was added to the
slurry of beads in buffer C (1:1) with 100 units of His-tagged
ProTEV protease per ml of Ni-beads. The protein was cleaved at
room temperature for 1–2 h, with gentle mixing, and then
incubated at 4uC overnight. The supernatant containing PEX3
was retained. A second incubation with Ni-charged beads
removed any traces of protease or other contaminants. The buffer
was exchanged either by ultrafiltration (10K cutoff, Amicon Ultra
Millipore) or by gel filtration on a Superdex 75 10/300 GL
column (GE Healthcare) into buffer C. The purified protein was
analyzed by SDS-PAGE and mass spectrometry and used within
2–3 days. Protein concentration measurements were done by UV
detection at 280 nm, using an extinction coefficient of 25
900 M21 cm21 [46].
PEX19 was purified by resuspending pelleted cells in buffer D
(50 mM Tris, 300 mM NaCl, 25 mM imidazole, pH 7.5) to which
Pefabloc SC (Sigma-Aldrich) was added to a final concentration of
0.5 mM and lysing the cells by French Press. After centrifugation
(22 0006g, 30 min, 4uC), the supernatant was loaded onto a
HisTrap column (GE Healthcare). The column was washed with
10 column volumes of the same buffer and the protein eluted with
a linear gradient of imidazole (25–500 mM). The peak fractions
were pooled and diluted 1:50 with buffer (50 mM Tris, 1 mM
DTT, pH 7.5) for loading onto an anion exchange column
(MonoQ FPLC, GE Healthcare). The column was washed with
buffer and the protein eluted with a linear NaCl gradient (0 to
1 M). The peak fractions were pooled and the buffer exchanged to
50 mM Tris, 300 mM NaCl, 1 mM DTT, pH 7.5. Finally, the
protein was concentrated to 0.4 mM by ultrafiltration (10K cutoff,
Amicon Ultra Millipore) and snap frozen in liquid nitrogen and
stored at 280uC until required. The protein concentration was
measured by UV detection at 280 nm, using an extinction
coefficient of 9970 M-1 cm-1 and the purity assessed by SDS
PAGE and mass spectrometry.
Native Mass Spectrometry
PEX3 was incubated with PEX19 in equimolar concentrations
(5–10 mM) overnight at 4uC in 20 mM sodium phosphate,
300 mM NaCl, 1 mM DTT, pH 8.0. ESI-MS spectra were
recorded on a QToF I (Waters/Micromass). Typically, 10 ml
solutions containing the PEX heterodimer were electrosprayed
from gold-coated glass capillaries (PicoTip, New Objective). To
preserve the non-covalent interactions of the PEX complex, the
MS parameters used for the QToF I were: capillary voltage, 1.3–
1.8 kV; sample cone, 120 V, analyzer pressure 7–961025 mbar;
time-of-flight analyzer pressure 7–961027 mbar. All spectra were
calibrated internally using a solution of cesium iodide (100 mg/
mL). Data were processed with MassLynx V4.0 software (Waters/
Micromass) with minimal smoothing and without background
subtraction [47].
Amide hydrogen (1H/2H) exchange monitored by mass
spectrometry (HXMS)
D2O (99.9 atom % D) was obtained from Merck (Darmstadt,
Germany). Isotopic exchange was initiated by diluting 5 ml of 200–
400 mM of each protein component in 200 ml deuterated PBS
buffer (0.14 M NaCl, 2.7 mM KCl, 12.5 mM Na2DPO4 and
1.7 mM g/l KD2PO4, pD 7.7 uncorrected value). The exchange
was carried out on ice for 0 min, 3 min, 7 min, 40 min and
60 min. The exchange was quenched by adding 8 ml 2.5% TFA.
As the PEX complexes precipitated upon freeze/thawing, the
samples were analyzed immediately rather than snap-freezing.
Water was used for the non-deuterated sample. To determine the
degree of back-exchange in the system, fully deuterated protein
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was prepared by incubation of the samples in 9 M deuterated urea
at pH 7.4 overnight at 25uC. Samples were prepared in duplicate.
The liquid chromatography (LC) setup was based on a system
described previously [48] with the following modifications:
Aqueous solution for desalting was delivered by a Pharmacia
LKB HPLC pump 2248 while an organic gradient for elution of
peptides/proteins was delivered by a Brownlee Labs MicroGra-
dient System (Applied Biosystems). Samples were loaded onto a
column packed with immobilized pepsin (Pierce, Rockford,
Illinois, USA) and digested for 15 s. The peptic peptides were
desalted for 2 min and eluted with a 9 min gradient (for 7 min,
from 12% to 40% acetonitrile, 0.05% TFA and an additional
2 min from 40% to 80% acetonitrile, 0.05% TFA). The LC system
was coupled to a QToF I (Waters/Micromass) mass spectrometer.
Spray voltage was 3.5 kV, cone voltage 40 V, and ion source block
temperature 120uC with a desolvation gas flow of 500 l/h at
200uC and nebulizing gas flow of 20 l/h at room temperature.
The HXMS data were analyzed by HX-Express [49]. To identify
peptic peptides, non-deuterated protein was digested and desalted
as described above. The peptic peptides were eluted and collected
for Nanoflow-LC-MS/MS analysis, which was carried out with an
UltiMate by LC Packings NanoLC coupled to the QToF I.
PEX19 and PEX3 peptic peptides were identified on the basis of a
comparative database search using the Mascot MS/MS ion search
engine [50] (Matrix Science, London, U.K.) on the generated
MS/MS spectra. The in-house database consisted of the human
wild-type PEX19 protein sequence and the PEX3 protein
sequence. The Mascot score was used to select the peptides with
the highest signal:noise ratio (the higher the score, the more
confident the result). The Mascot identifications of peptides were
subjected to an additional manual validation, where the number of
assigned fragment ions and their relative intensities and mass
accuracies were taken into account. The peptide ion signals were
extracted using MassLynx (Waters), smoothed with a Savitsky
Golay filter) and centered (four-channel minimum peak width at
half-height, 80% centroid top). The average masses were
calculated from the peak lists. Both the absolute and relative (to
full deuteration control) deuterium contents were calculated for
each time point. As duplicate exchange series were acquired for all
samples we calculated the mean error of the percentage deuterium
incorporation for all the duplicate measurements. This was 1.6%.
When peptides overlapped, those with the highest MASCOT
score were used. The overlapping peptides also showed that the
amount of the relative hydrogen-deuterium exchange was
consistent.
Results
Hydrogen exchange rates detect the internal motions of folded
protein, therefore the pattern of deuterium exchange reveals the
solvent accessibility and stability of local areas in the protein
sample when the protein undergo fluctuations that expose interior
sites to water. The experimental setup is to first incubate the
protein under native conditions in a deuterated buffer, allowing
exchange of amide hydrogens in the polypeptide. The exchange is
quenched by lowering the pH, the protein sample is fragmented by
pepsin digest and the resulting fragments are separated with
HPLC and analyzed by mass spectrometry. Deuterium incorpo-
ration into a peptide fragment causes a progressive mass increase,
which is followed over time by repeating the experiments, varying
the time of incubation in the deuterated buffer. HXMS
experiments were carried out in duplicate with high reproducibil-
Figure 2. Complex formation of PEX3 with PEX19 monitored by nano-electrospray MS. The spectra were recorded under conditions that
preserve non-covalent interactions showing A, MS on PEX3T-PEX19 heterodimer, B, PEX3 monomer and C, PEX19 monomer. Samples were analyzed
at 10 mM concentrations for the complex and five-fold higher for the monomers. No homodimers were detected in the spectra. The numbers of the
respective peaks represent the charge states. Relative intensities (%) are plotted against mass-over-charge (m/z).
doi:10.1371/journal.pone.0103101.g002
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ity, as we had a mean error of only 1.6% with a standard deviation
of 4.1% that would incorporate 95% of all of the data. Thus when
we report significant changes in the deuterium incorporation due
to complex formation, those are cases where the change is greater
than 1.6%.
Determining deuterium uptake profiles for PEX19 and
PEX3 monomers
We confirmed by native MS that both PEX19 and PEX3 were
monomeric under conditions similar to those used for HXMS, but
migrated as a 1:1 complex when mixed (Figure 2). The average
masses for PEX19, PEX3 and PEX3:PEX19 complex were
34.8 kDa, 57.4 kDa and 92.2 kDa respectively. These values are a
100 Da bigger than the average calculated mass as expected with
native MS as there is a contribution from water and salt adducts.
Next, we collected deuterium uptake data from 21 PEX19 and 32
PEX3 peptides, covering 93% and 98% of the protein sequences
respectively for the monomers and the complex (Figures 3–5). A
heat map of PEX19 (Figure 3A) was rendered from the individual
peptic peptide graphs (Figure S1). Where there were several
overlapping peptides, exhibiting a similar deuterium uptake profile
over time, peptides with the highest signal:noise ratio as defined
within the Mascot software [50] were selected to represent the
different local regions of PEX3 and PEX19 [47]. The N-terminal
part of the recombinant protein, corresponding to the His-tag and
the first three amino acids of PEX19, was not detected in the
HXMS experiments.
All PEX19 peptides from the N-terminal region A4 - L182, as
well as the C-terminal end F278 - L297 were already fully
deuterated after 30 seconds incubation in D2O (Figure 3A and
Figure S1) indicating that these areas, consisting of two thirds of
the protein, are highly solvent exposed and structurally disordered
[42]. In contrast, the region spanning amino acids L183 - N277
overall showed higher protection against deuterium uptake
indicating that it is structurally more ordered, forming a folded
core domain overlapping with the region 160–283 which has been
shown to crystallize [32].
HXMS on monomeric PEX3 showed a broad range of
deuterium uptake rates of the peptic peptides. These rates varied
from fully exchanged within 30 s of incubation in deuterated
buffer to less than 20% deuterium uptake after 60 min (Figure 4A,
Figure S2). Importantly, the local deuterium uptake observed here
is in accordance with the recently published structures [40,41]. For
example, the deeply buried a-helix segment spanning K108 -
M124 was highly protected while surface exposed and unstruc-
tured regions like A250 - T260 had a fast deuterium uptake rate
(Figure 4A).
Monitoring hydrogen exchange of the PEX3/PEX19
heterodimer
We first prepared a PEX3/PEX19 complex by titrating the
molar ratio and analyzing the sample by native MS. Uniform
complex formation was observed when incubating 5–10 mM
PEX3S with 5–10 mM PEX19 at 4uC overnight (Figure 2). This
agrees with earlier gel filtration and isothermal calorimetry
experiments indicating that the two proteins form a complex
[41]. Next we carried out HXMS on the uniform complex as
previously described for the monomers. The exchange rates of
individual peptides in the monomeric and heterodimeric forms
were compared to detect local changes in conformation induced
by complex formation.
Three areas with reduced deuterium uptake were found in
PEX19 in the complex (Figure 3B). First was the N-terminal
spanning region E13 – L21. The N-terminal sequence corre-
sponding to this area has been shown to bind the cytosolic region
of PEX3 previously and has been co-crystallized in two previous
studies [40,41]. The other two regions exhibiting reduced
deuterium uptake rates are a phenylalanine rich region represent-
ed by the F64 - L74 peptide and a stretch of amino acids at the
very C-terminus represented by the L183 - L297 peptides
(Figure 3B). Notably, peptides in the structured domain of
PEX19 (L193 - F248) did not exhibit any significant change in
deuterium uptake when PEX19 was bound to PEX3.
We mapped the peptic peptides obtained from the HXMS
experiments on the recently solved PEX3 structure [40,41] and
then compared the deuterium uptake profiles of the corresponding
peptides from the monomers and the complex. We found several
regions on the structure that became more shielded during binding
(Figures 4, 5, and Movie S1). One is the apical groove,
encompassing peptides L93 - L107, and V318 - C337, that has
previously been demonstrated to be a binding site for the N-
terminus of PEX19 [40,41]. Here, we have in addition located a
PEX3 area, facing the peroxisomal membrane which is affected by
PEX19 binding (Figure 1B). This area contains the peptic peptides
A52 - M67, A156 - S167 and I261 - E266 (Figure S2). The results
are consistent, shown by the similar behavior of overlapping peptic
peptides. However, when we mapped all of the peptides that have
any increase in protection on the PEX3 model, virtually the entire
surface was slightly protected (Figure 5 and Movie S1).
Discussion
The focus of this study was to use HXMS to examine
interaction sites between PEX3 and PEX19 and to track the
structural changes after complex formation. Our data have
revealed new insights into likely conformational changes of these
proteins in vitro. Our results confirmed that the PEX3:PEX19
complex involves the well-established interaction of the PEX19 N-
terminus with the apical groove of PEX3.
The N-terminal half (amino acids 1–155) of PEX19 has
previously been shown to be highly flexible as it is readily
degraded by limited proteolysis [21]. Our HXMS data clearly
show a rapid deuterium uptake rate in this area (Figure 3). In
addition, our data expanded this area (to 1–182 and 278–297) and
demonstrated that as almost two thirds of the protein has such a
high uptake rate of deuterium that it can be categorized as an
Figure 3. Comparison of hydrogen exchange in PEX19 alone and in complex with PEX3 monitored by MS. (A) HXMS heat map of PEX19
monomer summarizing the deuterium uptake over time. (B). HXMS heat map of PEX19 in the heterodimer with PEX3 summarizing the deuterium
uptake over time. (A and B). The sequence of the protein is shown above the heat map. Although the recombinant protein includes an N-terminal
tag only the full sequence of human PEX19 is shown with the numbering starting at the initial PEX19 methionine. The heat maps were assembled
from individual peptic peptides using MSTools [47]. The extent of the peptide is demarcated by vertical lines in each block, running through all four
time point bars, when there is a difference in uptake from the preceding or following peptide. All peptic peptides are shown in Figure S1. The scale
bar at the bottom of each heat map illustrates the color coding for deuterium uptake as a percentage. The horizontal bars from the top to the
bottom in each block of the heat map indicate incubation times of 0, 3, 7, 40 and 60 minutes, respectively. White bars represent the residues for
which no data were available.
doi:10.1371/journal.pone.0103101.g003
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intrinsically disordered protein when alone in solution (reviewed in
[51]).
Earlier studies have shown that when the N-terminal region of
PEX19 is removed, the protein can still bind PMPs, but no longer
localizes to the peroxisomal membranes [19,25,26,34]. Thus the
N-terminus of PEX19 is crucial for targeting PEX19 to
peroxisomal membranes in vivo, presumably via interaction with
PEX3. The in vitro binding of PEX3 and PEX19 has been studied
by surface plasma resonance, microcalorimetry and X-ray
crystallography [21,32,40,41,52]. The affinity of an N-terminal
PEX19 peptide was more than 10 fold lower than that for full-
length PEX19, implying that there may be more than one binding
site between PEX19 and PEX3. The co-crystallisation studies with
PEX3 only encompass the N-terminal PEX19 peptide (aa14–33).
However, they do indicate that this is the tightest binding site
along the PEX19. Here we report lower hydrogen-deuterium
exchange in the complex of the two full-length proteins. We
compared the exchange in both PEX19 and PEX3 after complex
formation. On PEX19, three significant changes occurred. The
changes in the N terminus agreed with previous binding affinity
assays and crystallography [21,32,40]. We saw that the PEX19
region E13-L21 was protected. This corresponds to the PEX19
peptide that has been shown to bind to a hydrophobic groove in
PEX3 [40,41]. A second protected site was seen in a phenylal-
anine-rich region spanning amino acids F64 - L74. This has the
potential to form a helix, as shown by an NMR study of PEX19-
PEX14 peptide interactions [53]. Sato et al. [40] reported that a
D45–90 mutant PEX19 can still bind to PEX3 as we would expect
for an extended interaction surface. Their pull-down assay did not,
however, quantitate the binding affinity. A third region of PEX19
located at the C-terminus (L183–L297), overlapped with the
folding core of PEX19 (I171–269) [32].
Addition of PEX19 caused extensive protection of four PEX3
peptides which mapped to the surface of the PEX3 structure at the
opposite end of the molecule to the hydrophobic groove. However,
mapping of all the increased protection on PEX3 due to PEX19
binding, indicated that there are probably subtle conformational
changes affecting most of the PEX3 surface (Figure 5 red surface,
and Movie S1).
Based on our MS data we propose the following model for
PEX19 binding to PEX3 at the peroxisomal membrane. Most
likely the N-terminus of PEX19 initiates the binding to PEX3, and
then subtle conformational changes in PEX3 affect the surface of
the PEX3 molecule. PEX19 in turn, is stabilized by folding of a
short helix, known to be important in PEX14 binding, and its C-
terminal folding core permitting PEX19 to bind to PEX3 with
higher affinity than just the N-terminal interaction allows. Thus
within the cell, PEX3 is stabilized by PEX19 preventing PEX3
Figure 4. Comparison of hydrogen exchange in PEX3 alone and in complex with PEX19 monitored by MS. A) HXMS heat map of PEX3
monomer summarizing the deuterium uptake over time. B) HXMS heat map of PEX3 in the heterodimer with PEX19 summarizing the deuterium
uptake over time. A) and B) The sequence of the PEX3 protein is shown above the heat map. The heat maps were assembled from individual peptic
peptides using MSTools [47]. The extent of the peptide is demarcated by vertical lines in each block, running through all four time point bars, when
there is a difference in uptake from the preceding or following peptide. All peptic peptides are shown in Figure S2. The scale bar at the bottom of
each heat map illustrates the color coding for deuterium uptake as a percentage. The horizontal bars from the top to the bottom in each block of the
heat map indicate incubation times of 0, 3, 7, 40 and 60 minutes, respectively. White bars represent the residues for which no data were available.
doi:10.1371/journal.pone.0103101.g004
Figure 5. The heat map of PEX3 plotted on the X-ray structure of PEX3 with a PEX19 peptide bound (PDB ID: 3AJB) [40]. Regions
where the hydrogen/deuterium exchange decreased in the heterodimer compared to PEX3 alone are shown in red. Regions where the exchange
remained the same are shown in blue. The left hand panel is rotated 180u along the Y axis compared to the right hand panel.
doi:10.1371/journal.pone.0103101.g005
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aggregation. The binding of PEX19 stabilises the membrane
proximal side of PEX3. The folding of the C-terminus of PEX19
on PEX3 binding could affect the observed farnesylation of
PEX19 [22].
The intrinsically disordered nature of PEX19, indicated by our
HDEX experiments may explain how it can carry out many
apparently different roles in the cell [42]. All of the following
functions that have been assigned to PEX19 are compatible with it
working as an IDP: PEX19 binding to newly translated PMPs in
the cytosol, thereby stabilizing them [21,25]; PEX19 as a
membrane insertion factor [33,54], as a factor for the association
and dissociation of protein complexes already in the membrane
[34] and as a shuttling receptor [3,19,25]. Recent developments in
the field of IDP have revealed that although some cooperative
folding and binding may be observed in IDP interactions, it can be
very limited and does not necessarily involve the whole of the
disordered region, instead these flexible linkers offer a platform for
multiple other coupling reactions in the cell. IDPs are tightly
regulated at all stages, from their synthesis which controls their
availability, by post-translational modifications affecting their
activity and interactions, to their degradation affecting their
overall life time. These measures help to maximize their specificity
[55,56]. We propose that PEX19 regulates many signaling
pathways in the cell as an IDP, exemplified by the PEX3:PEX19
interaction.
Supporting Information
Figure S1 Relative deuterium uptake of PEX19 peptic
peptides plotted over time. PEX19 monomer is colored in
blue (¤), PEX19:PEX3 complex in red (x).
(TIF)
Figure S2 Relative deuterium uptake of PEX3 peptic
peptides plotted over time. PEX3 monomer is indicated in
blue (¤), PEX3 bound to full-length PEX19 in red (&).
(TIF)
Movie S1 The heat map of PEX3 plotted on the X-ray
structure of PEX3 with a PEX19 peptide bound (PDB ID:
3AJB) [40]. Regions where the hydrogen/deuterium exchange
decreased in the heterodimer compared to PEX3 alone are shown
in red. Regions where the exchange remained the same are shown
in blue.
(MP4)
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